177 related articles for article (PubMed ID: 19569163)
21. Neonicotinic analogues: selective antagonists for α4β2 nicotinic acetylcholine receptors.
Faundez-Parraguez M; Farias-Rabelo N; Gonzalez-Gutierrez JP; Etcheverry-Berrios A; Alzate-Morales J; Adasme-Carreño F; Varas R; Bermudez I; Iturriaga-Vasquez P
Bioorg Med Chem; 2013 May; 21(10):2687-94. PubMed ID: 23561269
[TBL] [Abstract][Full Text] [Related]
22. Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.
Zhang H; Tückmantel W; Eaton JB; Yuen PW; Yu LF; Bajjuri KM; Fedolak A; Wang D; Ghavami A; Caldarone B; Paterson NE; Lowe DA; Brunner D; Lukas RJ; Kozikowski AP
J Med Chem; 2012 Jan; 55(2):717-24. PubMed ID: 22171543
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists.
Zhang HK; Eaton JB; Fedolak A; Gunosewoyo H; Onajole OK; Brunner D; Lukas RJ; Yu LF; Kozikowski AP
Eur J Med Chem; 2016 Nov; 124():689-697. PubMed ID: 27639361
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of α4β2 nicotinic receptor antagonists and partial-agonists on contextual fear extinction in male C57BL/6 mice.
Kutlu MG; Tumolo JM; Cann C; Gould TJ
Psychopharmacology (Berl); 2018 Apr; 235(4):1211-1219. PubMed ID: 29383396
[TBL] [Abstract][Full Text] [Related]
25. Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen.
Ogunjirin AE; Fortunak JM; Brown LL; Xiao Y; Dávila-García MI
Neurochem Res; 2015 Oct; 40(10):2131-42. PubMed ID: 26508288
[TBL] [Abstract][Full Text] [Related]
26. Cytisine-based nicotinic partial agonists as novel antidepressant compounds.
Mineur YS; Eibl C; Young G; Kochevar C; Papke RL; Gündisch D; Picciotto MR
J Pharmacol Exp Ther; 2009 Apr; 329(1):377-86. PubMed ID: 19164465
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice.
Akinola LS; Bagdas D; Alkhlaif Y; Jackson A; Gurdap CO; Rahimpour E; Carroll FI; Papke RL; Damaj MI
J Psychopharmacol; 2022 Nov; 36(11):1280-1293. PubMed ID: 36321267
[TBL] [Abstract][Full Text] [Related]
28. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
[TBL] [Abstract][Full Text] [Related]
29. Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors.
Jain A; Kuryatov A; Wang J; Kamenecka TM; Lindstrom J
J Biol Chem; 2016 Nov; 291(45):23452-23463. PubMed ID: 27645992
[TBL] [Abstract][Full Text] [Related]
30. Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
Huang Y; Zhu Z; Xiao Y; Laruelle M
Bioorg Med Chem Lett; 2005 Oct; 15(19):4385-8. PubMed ID: 16039849
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological and functional comparisons of α6/α3β2β3-nAChRs and α4β2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line.
Chen DJ; Gao FF; Ma XK; Shi GG; Huang YB; Su QX; Sudweeks S; Gao M; Dharshaun T; Eaton JB; Chang YC; Mcintosh JM; Lukas RJ; Whiteaker P; Steffensen SC; Wu J
Acta Pharmacol Sin; 2018 Oct; 39(10):1571-1581. PubMed ID: 29795357
[TBL] [Abstract][Full Text] [Related]
32. Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.
Lucero LM; Weltzin MM; Eaton JB; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P
J Biol Chem; 2016 Jan; 291(5):2444-59. PubMed ID: 26644472
[TBL] [Abstract][Full Text] [Related]
33. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
Hamouda AK; Deba F; Wang ZJ; Cohen JB
Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
[TBL] [Abstract][Full Text] [Related]
34. 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs.
Abdrakhmanova GR; Carroll FI; Damaj MI; Martin BR
Neuropharmacology; 2008 Dec; 55(8):1287-92. PubMed ID: 18775444
[TBL] [Abstract][Full Text] [Related]
35. α4β2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of α4β2 nAChR agonists in pain.
Lee CH; Zhu C; Malysz J; Campbell T; Shaughnessy T; Honore P; Polakowski J; Gopalakrishnan M
Biochem Pharmacol; 2011 Oct; 82(8):959-66. PubMed ID: 21763685
[TBL] [Abstract][Full Text] [Related]
36. Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
Bisson WH; Scapozza L; Westera G; Mu L; Schubiger PA
J Med Chem; 2005 Aug; 48(16):5123-30. PubMed ID: 16078832
[TBL] [Abstract][Full Text] [Related]
37. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
[TBL] [Abstract][Full Text] [Related]
38. Determinants for α4β2 vs. α3β4 Subtype Selectivity of Pyrrolidine-Based nAChRs Ligands: A Computational Perspective with Focus on Recent cryo-EM Receptor Structures.
Bavo F; Pallavicini M; Appiani R; Bolchi C
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204637
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and Behavioral Studies of Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part III.
Onajole OK; Vallerini GP; Eaton JB; Lukas RJ; Brunner D; Caldarone BJ; Kozikowski AP
ACS Chem Neurosci; 2016 Jun; 7(6):811-22. PubMed ID: 27035276
[TBL] [Abstract][Full Text] [Related]
40. The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile.
Yu LF; Brek Eaton J; Zhang HK; Sabath E; Hanania T; Li GN; van Breemen RB; Whiteaker P; Liu Q; Wu J; Chang YC; Lukas RJ; Brunner D; Kozikowski AP
Pharmacol Res Perspect; 2014 Apr; 2(2):e00026. PubMed ID: 25505580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
